Therapeutics against cancer and viral infections commonly suffer from several drawbacks including non-selective cytotoxicity, high immunogenicity and low circulation half-lives. The last decade has shown that these therapeutics have embraced conjugation of synthetic polymers and antibodies to therapeutic and cytotoxic payloads.
Maarten Danial
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Maarten
Contact Maarten, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack